Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Denosumab increases bone mineral density (BMD) in patients not receiving hemodialysis therapy. However, limited data are available in the literature concerning the use of denosumab in hemodialysis patients. We treated male hemodialysis patients with low radius BMD with denosumab therapy for 1 year a...

Descripción completa

Detalles Bibliográficos
Autores principales: Takami, Hiroya, Washio, Kazunori, Gotoh, Hiromichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585574/
https://www.ncbi.nlm.nih.gov/pubmed/28912972
http://dx.doi.org/10.1155/2017/6218129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585574/
https://www.ncbi.nlm.nih.gov/pubmed/28912972
http://dx.doi.org/10.1155/2017/6218129

Ejemplares similares